MJoTA (Medical Journal of Therapeutics Africa)

MiMW (MJoTA Institute of Medical Writing) - Emerald Pademelon Press LLC - MJoTA-NYEcho Partners

MJoTA Portal

20120517 Coffee NEJM

20120517coffee alzheimers

20120517 Coffee Japan

20120104 NCHS twins

20120104 land of twins

20120194 Igbo twins

20120501 NIH asthma

20120501 Asthma US Africa

20120501 Asthma home

Dr Susanna website

Ganymede Movies LLP

Registration page

20111229 asd cdc

20111229 Autism video

20111229 MMWR

MJoTA.org resources 2011

Vaccinations

Diabetes

Diabetes CME resources

Diabetes Podcasts

Amer J Diabetes

Malaria

Malaria Podcasts

Liver

HIV/AIDS

HIV/AIDS Podcasts

BI HIV drug

CDC HIV

Cancer

Cancer Podcasts

Tuberculosis

Daily Updates

MiMW Certificate

MiMW

Calendar

MiMW Resources

MJoTAtalks: Health

MJoTA pages

Search page

MJoTA masthead

Author guidelines

MJoTA publications

Front covers

MJoTA 2011

MJoTA 2010

MJoTA 2009

MJoTA 2008

MJoTA 2007

MJoTA Mentors

homework Dec 09

MJoTA Presenting yourself

Job Fair

Regulatory doc files

Protocols

Indian drugs resources

Indian drug regulations

Kenya drug regs

Nigerian drug regs

Libya

Book concept to shelf

Health Audio Podcasts

Caribbean Health Podcasts

African Health Dialogues

African Health Podcasts

Child Health Podcasts

Contact us

Tropical diseases movies

 
Loading

Pfizer Statement Regarding Article In The Guardian

December 9, 2010. NEW YORK, N.Y., December 9 - Pfizer Inc. issued the following statement today in response to an article published in The Guardian regarding purported cables from the U.S. embassy in Nigeria that discuss Pfizer.

“The Trovan cases brought by both the federal government of Nigeria and Kano State were resolved in 2009 by mutual agreement. Pfizer negotiated the settlement with the federal government of Nigeria in good faith and its conduct in reaching that agreement was proper. Although Pfizer has not seen any documents from the U.S. embassy in Nigeria regarding the federal government cases, any notion that the Company hired investigators in connection to the former Attorney General is simply preposterous.

“As previously disclosed in Pfizer’s 10-Q filing in November 2009, per the agreement with the federal government, Nigeria dismissed its civil and criminal actions against the Company. Pfizer denied any wrongdoing or liability in connection with the 1996 study. The Company agreed to pay the legal fees and expenses incurred by the federal government associated with the Trovan litigation. Pursuant to the settlement, payment was made to the federal government’s counsel of record in the case, and there was no payment made to the federal government of Nigeria itself. As is common practice, the agreement was covered by a standard confidentiality clause agreed to by both parties.


MJoTA.org. Published since 2006 by Emerald Pademelon Press LLC. PO Box 381 Haddonfield, NJ 08033, USA. 1-609-792-1571. Publisher@mjota.org